diluran 250mg - Keputusan Carian

prometheus laboratories inc. - azathioprine (unii: mrk240iy2l) (azathioprine - unii:mrk240iy2l) - azathioprine 50 mg - imuran is indicated as an adjunct for the prevention of rejection in renal homotransplantation. it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. renal homotransplantation: imuran is indicated as an adjunct for the prevention of rejection in renal homotransplantation. experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for hla antigens, anti-donor or anti-b-cell alloantigen antibody, and other variables. the effect of imuran on these variables has not been tested in controlled trials. rheumatoid arthritis: imuran is indicated for the treatment of active rheumatoid arthritis (ra) to reduce signs and symptoms. aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with imuran. the combined use of imuran with disease modifying anti-rheumatic drugs (dmards) has not been studied for either added benefit or unexpected adverse effects

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

imuran- azathioprine tablet

sebela pharmaceuticals inc. - azathioprine (unii: mrk240iy2l) (azathioprine - unii:mrk240iy2l) - azathioprine 50 mg - imuran is indicated as an adjunct for the prevention of rejection in renal homotransplantation. it is also indicated for the management of active rheumatoid arthritis to reduce signs and symptoms. renal homotransplantation: imuran is indicated as an adjunct for the prevention of rejection in renal homotransplantation. experience with over 16,000 transplants shows a 5-year patient survival of 35% to 55%, but this is dependent on donor, match for hla antigens, anti-donor or anti-b-cell alloantigen antibody, and other variables. the effect of imuran on these variables has not been tested in controlled trials. rheumatoid arthritis: imuran is indicated for the treatment of active rheumatoid arthritis (ra) to reduce signs and symptoms. aspirin, non-steroidal anti-inflammatory drugs and/or low dose glucocorticoids may be continued during treatment with imuran. the combined use of imuran with disease modifying anti-rheumatic drugs (dmards) has not been studied for either added benefit or unexpected adverse effects

Kesatuan Eropah - Portugis - EMA (European Medicines Agency)

edurant

janssen-cilag international n.v. - cloridrato de rilpivirina - infecções por hiv - antivirais para uso sistêmico - o edurant, em combinação com outros medicamentos anti-retrovirais, é indicado para o tratamento da infecção pelo vírus da imunodeficiência humana tipo 1 (hiv-1) em pacientes com tratamento anti-retroviral com idade igual ou superior a 12 anos com carga viral ≤ 100,000 cópias de rna do hiv-1 / ml. como com outros medicamentos anti-retrovirais, genotypic do teste de resistência deve orientar o uso de edurant.

Kesatuan Eropah - Iceland - EMA (European Medicines Agency)

edurant

janssen-cilag international n.v. - rilpivirin hýdróklóríð - hiv sýkingar - veirueyðandi lyf til almennrar notkunar - edurant, ásamt öðrum antiretroviral lyf, er ætlað fyrir meðferð hiv veira tegund 1 (hiv‑1) sýkingu í andretróveirumeðferð‑barnalegt sjúklingar 12 ára og eldri með veiru hlaða ≤ 100,000 hiv‑1 rna afrit/ml. eins og með aðrar antiretroviral lyf, arfgerðar mótstöðu prófa ætti að fylgja því að nota edurant.